Advanced search
Publication Cover
Leukemia & Lymphoma Volume 53, 2012 - Issue 6
Submit an article Journal homepage
321
Views
36
CrossRef citations to date
0
Altmetric
Research Articles

High rates of surveillance imaging for treated diffuse large B-cell lymphoma: findings from a large national database

Gregory A. AbelBrigham and Women's Hospital, Boston, MA, USA;Dana-Farber Cancer Institute, Boston, MA, USACorrespondence[email protected]
,
Ann VanderplasCity of Hope National Medical Center, Duarte, CA, USA
,
Maria A. RodriguezM. D. Anderson Cancer Center, Houston, TX, USA
,
Allison L. CrosbyDana-Farber Cancer Institute, Boston, MA, USA
,
Myron S. CzuczmanRoswell Park Cancer Institute, Buffalo, NY, USA
,
Joyce C. NilandDana-Farber Cancer Institute, Boston, MA, USA
,
Leo I. GordonRobert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA
,
Michael MillensonFox Chase Cancer Center, Philadelphia, PA, USA
,
Andrew D. ZelenetzMemorial Sloan-Kettering Cancer Center, New York, NY, USA
,
Jonathan W. FriedbergJames P. Wilmot Cancer Center, Rochester, NY, USA
&
Ann S. LaCasceBrigham and Women's Hospital, Boston, MA, USA;Dana-Farber Cancer Institute, Boston, MA, USA
 show all
Pages 1113-1116 | Received 25 May 2011, Accepted 07 Nov 2011, Published online: 03 Feb 2012

References

  • Weeks JC, Yeap BY, Canellos GP, . Value of follow-up procedures in patients with large-cell lymphoma who achieve a complete remission. J Clin Oncol 1991;9:1196–1203.
  • Guppy AE, Tebbutt NC, Norman A, . The role of surveillance CT scans in patients with diffuse large B-cell non-Hodgkin's lymphoma. Leuk Lymphoma 2003;44:123–125.
  • Liedtke M, Hamlin PA, Moskowitz CH, . Surveillance imaging during remission identifies a group of patients with more favorable aggressive NHL at time of relapse: a retrospective analysis of a uniformly-treated patient population. Ann Oncol 2006;17:909–913.
  • Juweid ME, Wiseman GA, Vose JM, . Response assessment of aggressive non-Hodgkin's lymphoma by integrated International Workshop Criteria and fluorine-18-fluorodeoxyglucose positron emission tomography. J Clin Oncol 2005;23:4652–4661.
  • Seam P, Juweid ME, Cheson BD. The role of FDG-PET scans in patients with lymphoma. Blood 2007;110:3507–3516.
  • Zinzani PL, Stefoni V, Tani M, . Role of [18F]fluorodeoxyglucose positron emission tomography scan in the follow-up of lymphoma. J Clin Oncol 2009;27:1781–1787.
  • Edelman MJ, Meyers FJ, Siegel D. The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 1997;12:318–331.
  • Elis A, Blickstein D, Klein O, . Detection of relapse in non-Hodgkin's lymphoma: role of routine follow-up studies. Am J Hematol 2002;69:41–44.
  • LaCasce AS, Kho ME, Friedberg JW, . Comparison of referring and final pathology for patients with non-Hodgkin's lymphoma in the National Comprehensive Cancer Network. J Clin Oncol 2008;26:5107–5112.
  • Juweid ME. 18F-FDG PET as a routine test for posttherapy assessment of Hodgkin's disease and aggressive non-Hodgkin's lymphoma: where is the evidence? J Nucl Med 2008;49:9–12.
  • Smith-Bindman R, Lipson J, Marcus R, . Radiation dose associated with common computed tomography examinations and the associated lifetime attributable risk of cancer. Arch Intern Med 2009;169:2078–2086.
  • Gisselbrecht C, Glass B, Mounier N, . Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era. J Clin Oncol 2010;28:4184–4190.
  • Rogers EM. Diffusion of innovations. Toronto, Ontario: Free Press; 2003.
  • Bodenheimer T. High and rising health care costs. Part 2: technologic innovation. Ann Intern Med 2005;142:932–937.
  • Mitchell JM. Utilization trends for advanced imaging procedures: evidence from individuals with private insurance coverage in California. Med Care 2008;46:460–466.
  • Dinan MA, Curtis LH, Hammill BG, . Changes in the use and costs of diagnostic imaging among Medicare beneficiaries with cancer, 1999-2006. JAMA 1625;303:1625–1631.
  • Cheson B. The case against heavy PETing. J Clin Oncol 2009;27:1742–1743.
  • Armitage JO, Loberiza FR. Is there a place for routine imaging for patients in complete remission from aggressive lymphoma? Ann Oncol 2006;17:883–884.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.